Vitamin C-Infused stent takes on heart disease in major trial
Disease control
Not yet recruiting
This study compares a new stent that slowly releases sirolimus and vitamin C (D+Storm Novonix) to a standard stent (Synergy XD) in about 2,000 people with coronary artery disease who need a procedure to open blocked heart arteries. The goal is to see if the new stent is at least …
Phase: NA • Sponsor: Jung-min Ahn • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC